OmniPathology Attends 2025 National Society of Histotechnology (NSH) Convention
Dr. Ronald Blum, Vice President of Science & Technology for OmniPathology met with Katrinia Logemann, Sales Specialist, Healthcare Pathology Imaging for Leica Biosystems, to discuss Leica’s innovative workfl ow solutions designed to advance cancer diagnostics. Their conversation highlighted Leica’s world-class digital imaging systems, which are transforming how laboratories manage, interpret, and share pathology data.
Dr. Ronald Blum, Vice President of Science & Technology for OmniPathology also met with David Muirhead, MSA, IAMLS, AIBMS, ARMS, Account Executive for Roche Tissue Diagnostics, to discuss the company’s latest innovations in automated slide staining, sample tracking, and digital pathology solutions. These advancements have the potential to enhance diagnostic accuracy and streamline laboratory workflows.
OmniPathology was proud to participate in the 2025 National Society of Histotechnology (NSH) Convention, joining leaders from across the nation to explore innovations shaping the future of histology and pathology.
Long Beach, CA, September 26–30, 2025 – OmniPathology’s Vice President of Science & Technology, Dr. Ronald Blum, attended the 2025 National Society of Histotechnology (NSH) Convention, the largest histology-focused gathering in the United States. The annual event brings together leading experts, innovators, and vendors to showcase the latest advancements in laboratory equipment, workfl ow solutions, and diagnostic technologies for pathology laboratories.
During the convention, Dr. Blum met with several key industry leaders to explore emerging technologies that align with OmniPathology’s mission to deliver precise, efficient, and cutting-edge diagnostic services.
OmniPathology remains committed to adopting and integrating advanced technologies that improve patient outcomes and laboratory performance. Attendance at national conferences such as the NSH Convention underscores the organization’s dedication to staying at the forefront of pathology innovation.
Learn more about OmniPathology’s commitment to innovation at www.omnipathology.com.
Dr. Ronald Blum, Vice President of Science & Technology at OmniPathology, participated in Pathology Visions 2025 at the Manchester Grand Hyatt, engaging with digital pathology and AI experts to explore the latest breakthroughs in diagnostic imaging and data analytics.
